If you’re looking at investing at the small side of the market, I think the three small caps listed below could be worth considering.
While there is certainly still a lot of work to be done, they all appear to be carving out bright futures for themselves.
Here’s why I think they should be on your watchlist:
Alcidion Group Ltd (ASX: ALC)
Alcidion is a fast-growing health informatics company which is aiming to transform healthcare with smart, intuitive technology solutions. It has a growing portfolio of software products and services such as Miya Precision, Smartpage and Patientrack. Combined, they support interoperability, allow communication and task management, and deliver clinical decision support at the point of care to improve patient outcomes.
Serko Ltd (ASX: SKO)
Serko is an online travel booking and expense management provider behind the Zeno Travel and Zeno Expense platforms. Zeno Travel provides AI-powered end-to-end travel itineraries, cost control and travel policy compliance to corporate customers. Whereas the latter platform allows its users to automate and streamline the expense administration function, identify out-of-policy expense claims, and prevent fraud. While Serko’s growth will be hit hard by the pandemic, I believe it will bounce back strongly when travel markets return to normal. Until then, it looks well-funded to ride out the storm.
Volpara Health Technologies Ltd (ASX: VHT)
Volpara is a Software-As-A-Service (SaaS) company that leverages artificial intelligence to improve the early detection of breast cancer by analysing mammograms and associated patient data. After which, the software is able to provide clinical decision support and practice management tools and a cost-effective way. But most importantly, it can be used to reduce breast cancer deaths. The company is currently generating NZ$18 million in annual recurring revenues (ARR), but estimates that it has a US$750 million ARR opportunity in breast cancer screening.
Looking for more exciting companies? Then check out the recommendation below which one analyst is urging investors to go all in with…
One “All In” ASX Buy Alert, that could be one of our greatest discoveries
Investing expert Scott Phillips has just named what he believes is the #1 Top “Buy Alert” after stumbling upon a little-owned opportunity he believes could be one of the greatest discoveries of his 25 years as a professional investor.
This under-the-radar ASX recommendation is virtually unknown among individual investors, and no wonder.
What it offers is an utterly unique strategy to position yourself to potentially profit alongside some of the world’s biggest and most powerful tech companies.
Potential returns of 1X, 2X and even 3X are all in play. Best of all, you could hold onto this little-known equity for DECADES to come.
Simply click here to see how you can find out the name of this ‘all in’ buy alert… before the next stock market rally.
More reading
- These small cap ASX shares could be stars of the future
- Could these small cap ASX shares be the next Afterpay?
- 3 exciting ASX healthcare shares to watch in the 2020s
- 3 exciting small cap ASX shares to invest $3,000 into right now
- Why these 4 exciting ASX tech shares are soaring higher today
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Alcidion Group Ltd and Serko Ltd. The Motley Fool Australia owns shares of and has recommended VOLPARA FPO NZ. The Motley Fool Australia has recommended Alcidion Group Ltd and Serko Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post 3 exciting small cap ASX shares that should be on your watchlist appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/2XiJi2n
Leave a Reply